Literature DB >> 10966171

Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage.

S Capalbo1, P Trerotoli, A Ciancio, C Battista, G Serio, V Liso.   

Abstract

We assessed the familial aggregation of chronic lymphoproliferative diseases (CLD) in 3962 relatives of 169 patients with B-cell chronic lymphocytic leukemia (B-CLL). Data collection included a self-administered questionnaire. The "relative risk" considered the connection between a higher incidence of CLD and the degree of familial linkage with the probands. The model of logistic regression was statistically significant (p < 0.001), with the probability of CLD increasing in proportion to the relationship coefficient between parents, siblings and children [(relationship coefficient 0.5; probability of CLD 1.85 (C.I. 95%, range 1.1-3%)]. CLD, particularly B-CLL, were observed in first-degree relatives of the patients with B-CLL more often than in other relatives.

Entities:  

Mesh:

Year:  2000        PMID: 10966171     DOI: 10.1034/j.1600-0609.2000.90183.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

Review 1.  Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Authors:  Paolo Strati; Tait D Shanafelt
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

2.  Survival patterns among lymphoma patients with a family history of lymphoma.

Authors:  Lesley A Anderson; Ruth M Pfeiffer; Joshua S Rapkin; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

3.  Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future.

Authors:  Jennifer R Brown
Journal:  Ther Adv Hematol       Date:  2013-08

4.  Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

Authors:  Ola Landgren; Eric A Engels; Neil E Caporaso; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Martha S Linet; Lynn R Goldin
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

Review 5.  Inherited predisposition to chronic lymphocytic leukemia.

Authors:  Jennifer R Brown
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

6.  Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.

Authors:  Silvana Capalbo; Vincenzo Callea; Caterina Musolino; Patrizia Guglielmo; Giovanni D'Arena; Alberto Fragasso; Cosima Battista; Rosario Giustolisi; Maura Brugiatelli; Vincenzo Liso
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

7.  Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.

Authors:  C Dong; K Hemminki
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

8.  Lung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literature.

Authors:  Aldo Pezzuto; Alessio Piraino; Salvatore Mariotta
Journal:  Oncol Lett       Date:  2014-11-20       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.